Daniel Barber's most recent trade in Aquestive Therapeutics Inc was a trade of 20,369 Common Stock done at an average price of $4.0 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 15 Jul 2026 | 20,369 | 610,574 (1%) | 0% | 4.0 | 81,509 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 15 Jul 2026 | 4,631 | 630,943 (1%) | 0% | 4.0 | 18,683 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Sale of securities on an exchange or to another person at price $ 4.16 per share. | 15 Jun 2026 | 25,000 | 635,574 (1%) | 0% | 4.2 | 104,010 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 15 May 2026 | 8,257 | 660,574 (1%) | 0% | 4.3 | 35,413 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.18 per share. | 05 May 2026 | 335,922 | 668,831 (2%) | 1% | 4.2 | 1,404,154 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 523,000 | 523,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 262,000 | 1,185,430 (3%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Sale of securities on an exchange or to another person at price $ 4.17 per share. | 09 Mar 2026 | 180,677 | 1,004,753 (3%) | 0% | 4.2 | 753,965 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 26 Sep 2025 | 91,343 | 923,430 (2%) | 0% | 6.0 | 551,191 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 19 Sep 2025 | 400 | 1,014,773 (3%) | 0% | 6 | 2,400 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 408,000 | 408,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 293,100 | 293,100 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 272,000 | 1,098,478 (3%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 53,998 | 1,015,173 (3%) | 0% | 2.7 | 143,095 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 29,307 | 1,069,171 (3%) | 0% | 2.7 | 77,664 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 56,824 | 826,478 (2%) | 0% | 4.9 | 277,301 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 37,938 | 845,364 (2%) | 0% | 4.9 | 185,137 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 363,900 | 363,900 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 242,600 | 883,302 (2%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 223,500 | 223,500 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 223,500 | 223,500 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 447,000 | 640,702 (1%) | 1% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 91,743 | 91,743 | - | - | Warrant (Right to Buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 91,743 | 193,702 (0%) | 0% | 1.0 | 88,073 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 225,000 | 225,000 | - | - | Non-Qualified Stock Option (right to buy) |